Updated Findings from bluebird bio

• bluebird bio analyses demonstrate lentiviral vector BB305 unlikely to be the cause of AML in a clinical study of LentiGlobin for SCD
• bluebird bio initiated a process with regulators to resume clinical studies

bluebird bio (BLUE)